RecruitingNot ApplicableNCT06150599

Sacral Neuromodulation for Chronic Pelvic Pain

Sacral Neuromodulation for the Treatment of Chronic Pelvic Pain

Sponsor

Corewell Health East

Enrollment

25 participants

Start Date

Jan 27, 2026

Study Type

INTERVENTIONAL

Conditions

Chronic Pelvic Pain Syndrome

Summary

Sacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we are assessing the effectiveness of sacral neuromodulation in women with suffering from chronic pelvic pain (CPP), through a single device implant procedure.

Eligibility

Sex: FEMALEMin Age: 22 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Sacral neuromodulation for people with chronic pelvic pain syndrome. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 22 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.